CME Group (CME) – Analysts’ Recent Ratings Updates

Several analysts have recently updated their ratings and price targets for CME Group (NASDAQ: CME):

• 2/14/2025 – CME Group had its price target raised by analysts at Keefe, Bruyette & Woods from $256.00 to $257.00. They now have a “market perform” rating on the stock.
• 2/13/2025 – CME Group had its price target raised by analysts at JPMorgan Chase & Co. from $209.00 to $212.00. They now have an “underweight” rating on the stock.
• 2/13/2025 – CME Group had its price target raised by analysts at Royal Bank of Canada from $235.00 to $269.00. They now have a “sector perform” rating on the stock.
• 2/13/2025 – CME Group had its price target raised by analysts at Oppenheimer Holdings Inc. from $258.00 to $269.00. They now have an “outperform” rating on the stock.
• 2/13/2025 – CME Group had its price target raised by analysts at Barclays PLC from $257.00 to $263.00. They now have an “equal weight” rating on the stock.
• 1/13/2025 – CME Group had its price target lowered by analysts at Keefe, Bruyette & Woods from $260.00 to $256.00. They now have a “market perform” rating on the stock.
• 1/7/2025 – CME Group had its price target raised by analysts at Piper Sandler from $250.00 to $258.00. They now have an “overweight” rating on the stock.
• 1/6/2025 – CME Group had its “sector perform” rating reaffirmed by analysts at Royal Bank of Canada. They now have a $235.00 price target on the stock.
• 1/6/2025 – CME Group was downgraded by analysts at Citigroup Inc. from a “buy” rating to a “neutral” rating. They now have a $250.00 price target on the stock, down previously from $255.00.
• 12/20/2024 – CME Group had its price target raised by analysts at Keefe, Bruyette & Woods from $237.00 to $260.00. They now have a “market perform” rating on the stock.

CME Group Stock Down 1.9 %

Shares of CME Group stock opened at $245.48 on Tuesday. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.09. CME Group Inc. has a 12 month low of $190.70 and a 12 month high of $253.53. The business has a fifty day simple moving average of $235.95 and a 200 day simple moving average of $226.00. The stock has a market cap of $88.46 billion, a PE ratio of 25.81, a price-to-earnings-growth ratio of 5.54 and a beta of 0.57.

CME Group (NASDAQ:CME) last issued its quarterly earnings data on Wednesday, February 12th. The financial services provider reported $2.52 EPS for the quarter, topping analysts’ consensus estimates of $2.46 by $0.06. CME Group had a net margin of 57.34% and a return on equity of 13.39%. Research analysts predict that CME Group Inc. will post 10.18 EPS for the current year.

CME Group Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Wednesday, March 26th. Investors of record on Friday, March 7th will be issued a dividend of $1.25 per share. This is an increase from CME Group’s previous quarterly dividend of $1.15. The ex-dividend date is Friday, March 7th. This represents a $5.00 annualized dividend and a dividend yield of 2.04%. CME Group’s payout ratio is presently 48.37%.

Insider Buying and Selling

In other CME Group news, insider Julie Winkler sold 11,592 shares of the business’s stock in a transaction dated Thursday, February 13th. The shares were sold at an average price of $249.17, for a total value of $2,888,378.64. Following the completion of the sale, the insider now owns 21,885 shares of the company’s stock, valued at $5,453,085.45. The trade was a 34.63 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. 0.30% of the stock is currently owned by insiders.

Hedge Funds Weigh In On CME Group

Several hedge funds and other institutional investors have recently made changes to their positions in the company. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC increased its position in CME Group by 14.9% during the 4th quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 2,437,662 shares of the financial services provider’s stock worth $566,098,000 after purchasing an additional 315,813 shares in the last quarter. Waverly Advisors LLC increased its position in CME Group by 32.2% during the 4th quarter. Waverly Advisors LLC now owns 10,827 shares of the financial services provider’s stock worth $2,514,000 after purchasing an additional 2,637 shares in the last quarter. Woodline Partners LP acquired a new position in CME Group during the 4th quarter worth approximately $5,026,000. Sone Capital Management LLC acquired a new position in CME Group during the 4th quarter worth approximately $8,049,000. Finally, Vident Advisory LLC increased its position in CME Group by 125.7% in the 4th quarter. Vident Advisory LLC now owns 17,072 shares of the financial services provider’s stock valued at $3,965,000 after acquiring an additional 9,508 shares during the period. 87.75% of the stock is currently owned by institutional investors and hedge funds.

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.